Thursday, October 8

Healthcare

Stifel starts ORIC at purchase, cites prostate cancer drug candidate

09/07/20241 Min Read

buy cancer candidate cites drug ORIC prostate starts Stifel

Previous ArticleCatalyst Watch: Apple's iPhone occasion, Oracle earnings, Google antitrust trial, and the August CPI print

Next Article Allurion started at buy by Roth MKM over weight-loss device potential